Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01728545 · ClinicalTrials.gov registry record
The Collection and Storage of Umbilical Cord Blood for Transplantation
A clinical trial of Hematopoietic Stem Cell Transplantation and Cord Blood Stem Cell Transplantation, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 250,000
- Enrollment target
- 1
- Study location
NCT01728545: Recruiting study of Hematopoietic Stem Cell Transplantation and Cord Blood Stem Cell Transplantation, sponsored by M.D. Anderson Cancer Center.
NCT01728545 is a study of Hematopoietic Stem Cell Transplantation and Cord Blood Stem Cell Transplantation that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 250,000 participants, above the 174-participant average among 26 other Hematopoietic Stem Cell Transplantation trials with a reported enrollment target (143578% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01728545, a study of Hematopoietic Stem Cell Transplantation and Cord Blood Stem Cell Transplantation, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 250,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to collect blood samples from the umbilical cords of newborn babies, as soon as they are delivered, and to place these samples in the MD Anderson Cord Blood Bank. Your sample may be included in the National Cord Blood Inventory (NCBI) which is part of the CW Bill Young Cell Transplantation Program. The NCBI is a federally-supported program to assist in the collection of cord blood. Cord blood will be made available to patients through The National Marrow Donor Program (NMDP). These samples may then be offered to MD Anderson and other institutions for patients who need a bone marrow transplant and do not have a donor. The MD Anderson Cord Blood Bank will have the rights to release cord blood units to these institutions around the world according to established bone marrow transplant donor criteria, for a fee to cover costs. Cord blood samples that are collected and then do not meet the clinical requirements for patient use may also be used at MD Anderson or other institutions either for research or for quality purposes to improve cord blood banking procedures. If not suitable for patient use or for research purposes, the cord blood unit may be thrown away.
Primary Outcome
Collection and storage of umbilical cord blood units from normal donors for banking and ultimate transplantation into patients.
Conditions Studied
Study Locations (1)
Texas
- MD Anderson Cord Blood Bank Collection Sites - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250,000 participants |
| Start Date | 2005-04 |
| Est. Completion | 2099-04 |
What NCT01728545 shows while recruiting
NCT01728545 is an observational study that tracks outcomes without assigning an intervention. Its 250,000 participants enrollment target places it among the larger protocols in the corpus, above the 174-participant average among 26 other Hematopoietic Stem Cell Transplantation trials with a reported enrollment target (143578% higher).
The record links to 3 conditions, with Hematopoietic Stem Cell Transplantation appearing as the primary indexed condition, and to 0 interventions.
NCT01728545 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT01728545 about?
NCT01728545 is a clinical study titled "The Collection and Storage of Umbilical Cord Blood for Transplantation". The goal of this study is to collect blood samples from the umbilical cords of newborn babies, as soon as they are delivered, and to place these samples in the MD Anderson Cord Blood Bank. Your sample may be included in the National Cord Blood Inventory (NCBI) which is part of the CW Bill Young Cell...
What is the current status of trial NCT01728545?
This trial is currently recruiting. The enrollment target is 250,000 participants. The study started on 2005-04. Estimated completion is 2099-04.
What conditions does trial NCT01728545 study?
This clinical trial studies the following conditions: Hematopoietic Stem Cell Transplantation, Cord Blood Stem Cell Transplantation, Cord Blood Transplantation.
Who is sponsoring clinical trial NCT01728545?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01728545 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hematopoietic Stem Cell Transplantation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01728545's enrollment target sits among peer trials
250,000 1st of 26 higher than 26 of 26 other Hematopoietic Stem Cell Transplantation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hematopoietic Stem Cell Transplantation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
RECRUITING · Phase 1
-
Employment Support After Hematopoietic Stem Cell Transplantation
RECRUITING · NA
-
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
RECRUITING · Phase 2
-
Metagenomics Next-generation Sequencing Approach to Detect Microbial DNA/RNA Overtime in Individuals Undergoing Hematopoietic Stem Cell Transplant
RECRUITING
-
Long-Term Follow-up of People Undergoing Hematopoietic Stem Cell Transplantation
RECRUITING
-
Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04735835 · 250,000 participants · NA
Personalized Responses to Dietary Composition Trial 3
- NCT02280733 · 300,000 participants
A Real-World Registry of Chronic Wounds and Ulcers
- NCT06694181 · 300,000 participants
Safe and Explainable AI
- NCT07314697 · 300,000 participants · NA
Arrival Time Implementation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia